News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Daiichi Sankyo Co Ltd. Says Offer for Ranbaxy Laboratories Oversubscribed
September 24, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, Sept 24 (Reuters) - Japan's third-largest drugmaker Daiichi Sankyo Co said on Wednesday its open offer to buy up to 20 percent of India's generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Daiichi Sankyo
MORE ON THIS TOPIC
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
April 8, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
April 7, 2026
·
2 min read
·
Heather McKenzie
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
April 6, 2026
·
2 min read
·
Tristan Manalac
